Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Kazuya Sakai, MD, Hideo Yagi, MD, Masaki Hayakawa, MD, Tatsuhiko Someya, PhD, Kaori Harada, PhD, Masanori Matsumoto, MD

Blood (2018) 132 (Supplement 1): 2522.

https://doi.org/10.1182/blood-2018-99-113948

Published: 2018

Journal Articles

Metabolic Profiling Identifies De Novo Nucleotide Synthesis As a Potential Metabolic Vulnerability for Targeted Therapy Against Mantle Cell Lymphoma

Yixin Yao, PhD, Yang Liu, PhD, Hui Guo, PhD, Makhdum Ahmed, MD PhD MPH, Shabnam Bhuiyan, MSc, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 2945.

https://doi.org/10.1182/blood-2018-99-112192

Published: 2018

Journal Articles

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Blood (2018) 132 (Supplement 1): 211.

https://doi.org/10.1182/blood-2018-99-116411

Published: 2018

Journal Articles

Novel Structurally-Modified Allosteric Effectors of Hemoglobin Exhibit Superior Antisickling Properties

Osheiza Abdulmalik, DVM, MS, Tanvi Deshpande, MS, Mohini Ghatge, PhD, Yan Zhang, PhD, Jurgen Venitz, MDPhD, Apurvasena Parikh, PhD, Martin K. Safo, PhD

Blood (2014) 124 (21): 218.

https://doi.org/10.1182/blood.V124.21.218.218

Published: 2014

Journal Articles

Clinical and Preclinical Characterisation Of The Metabolites Of The BCR-ABL Tyrosine Kinase Inhibitor Nilotinib

Paul W. Manley, Ph. D., Jürgen Mestan, Ph D, Jennifer Sheng, Ph D, Phi Tran, M Sc, Mark Kagan, Ph D

Blood (2013) 122 (21): 4011.

https://doi.org/10.1182/blood.V122.21.4011.4011

Published: 2013

Journal Articles

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736,

Andrew S. Moore, MBBS, FRACP, Amir Faisal, Vassilios Bavetsias, David Gonzalez de Castro, PhD, Chongbo Sun, Butrus Atrash, Melanie Valenti, Alexis de Haven Brandon, Sian Avery, Andrew DJ Pearson, Paul Workman, Julian Blagg, Florence I Raynaud, Suzanne A Eccles, Spiros Linardopoulos

Blood (2011) 118 (21): 3492.

https://doi.org/10.1182/blood.V118.21.3492.3492

Published: 2011

Journal Articles

Anti-Leukemic Activity of PIK-75, a PI3-Kinase p110α Selective Inhibitor, In Acute Myeloid Leukemia

François Vergez, Jean-Emmanuel Sarry, Nathalie Gallay, Camille Fialin, Sarah Scotland, Cécile Demur, Peter Shepherd, Gwenn-ael Danet-Desnoyer, Anna Kruczynski, Bernard Payrastre, Stéphane Manenti, Christian Recher

Blood (2010) 116 (21): 659.

https://doi.org/10.1182/blood.V116.21.659.659

Published: 2010

Journal Articles

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3 -ITD Positive AML In Vitro and In Vivo

Andrew S Moore, Amir Faisal, Vassilios Bavetsias, Chongbo Sun, Butrus Atrash, Melanie Valenti, Alexis de Haven Brandon, Sian Avery, Florence I Raynaud, Paul Workman, Andrew DJ Pearson, Julian Blagg, Suzanne A Eccles, Spiros Linardopoulos

Blood (2010) 116 (21): 3289.

https://doi.org/10.1182/blood.V116.21.3289.3289

Published: 2010

Journal Articles

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Santina Bruzzone, Ph.D., Floriana Fruscione, Sara Morando, Alessandro Poggi, Anna Garuti, Martina Selmo, Tiziana Ferrando, Federica Benvenuto, Michele Cea, MD, Debora Soncini, Eva Moran, Ph.D., Ilaria Rocco, Gabriella Cirmena, Gabriele Zoppoli, MD, Alberto Ballestrero, MD, Ph.D., Bernard Sordat, Franco Patrone, Antonio Uccelli, Alessio Nencioni, MD, Ph.D.

Blood (2009) 114 (22): 4732.

https://doi.org/10.1182/blood.V114.22.4732.4732

Published: 2009

Journal Articles

Detection of Leukemia in MLL-AF9 Transgenic Mice Using Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

Deborah DeRyckere, Ph.D., Natalie Serkova, Ph.D., Margaret E. Macy, M.D., Lori A. Gardner, B.A., Paul Jedlicka, M.D., Ph.D., Kendra M. Hasebroock, B.S., Lia Gore, M.D.

Blood (2008) 112 (11): 760.

https://doi.org/10.1182/blood.V112.11.760.760

Published: 2008

Journal Articles

Pyrrolo[2,3- b ]Pyridinic Derivatives Induce Cell Growth Inhibition of the Myeloblastic HL-60 Cell Line.

Maylis Decrop, PharmD, Claire Espanel, MD, Jerome Guillard, PhD, Elodie Boissier, PharmD, Nathalie Gallay, PhD, Christian Binet, MD, Marie-Claude Viaud-Massuard, PhD, Olivier Herault, MD, PhD

Blood (2006) 108 (11): 4400.

https://doi.org/10.1182/blood.V108.11.4400.4400

Published: 2006

Journal Articles

Molecular Interactions between the Highly Selective pan-Bcr-Abl Inhibitor, AMN107, and the Tyrosine Kinase Domain of Abl.

Paul W. Manley, Sandra W. Cowan-Jacob, Gabriele Fendrich, Jürgen Mestan

Blood (2005) 106 (11): 3365.

https://doi.org/10.1182/blood.V106.11.3365.3365

Published: 2005

Journal Articles

A Novel Heterologous Expression System for Characterization of Individual NADH-Cytochrome b 5 Reductase Variants in Recessive Congenital Methemoglobinemia.

Melanie J. Percy, PhD, L. J. Crowley, PhD, C. A. Davis, PhD, J. Boudreaux, MD, D. M. Layton, MD, M. F. McMullin, MD, T. R. Lappin, PhD, M. J. Barber, DPhil

Blood (2005) 106 (11): 1676.

https://doi.org/10.1182/blood.V106.11.1676.1676

Published: 2005

Journal Articles

A Series of New Screening Procedures for Pyruvate Kinase Deficiency, Glucose-6-Phosphate Dehydrogenase Deficiency, and Glutathione Reductase Deficiency

ERNEST BEUTLER, M.D., Agnes Halasz

Blood (1966) 28 (4): 553–562.

https://doi.org/10.1182/blood.V28.4.553.553

Published: 1966

NARROW

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Metabolic Profiling Identifies De Novo Nucleotide Synthesis As a Potential Metabolic Vulnerability for Targeted Therapy Against Mantle Cell Lymphoma

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Novel Structurally-Modified Allosteric Effectors of Hemoglobin Exhibit Superior Antisickling Properties

Clinical and Preclinical Characterisation Of The Metabolites Of The BCR-ABL Tyrosine Kinase Inhibitor Nilotinib

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736,

Anti-Leukemic Activity of PIK-75, a PI3-Kinase p110α Selective Inhibitor, In Acute Myeloid Leukemia

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3 -ITD Positive AML In Vitro and In Vivo

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Detection of Leukemia in MLL-AF9 Transgenic Mice Using Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

Pyrrolo[2,3- b ]Pyridinic Derivatives Induce Cell Growth Inhibition of the Myeloblastic HL-60 Cell Line.

Molecular Interactions between the Highly Selective pan-Bcr-Abl Inhibitor, AMN107, and the Tyrosine Kinase Domain of Abl.

A Novel Heterologous Expression System for Characterization of Individual NADH-Cytochrome b 5 Reductase Variants in Recessive Congenital Methemoglobinemia.

A Series of New Screening Procedures for Pyruvate Kinase Deficiency, Glucose-6-Phosphate Dehydrogenase Deficiency, and Glutathione Reductase Deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only